These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 34229529)

  • 21. A Case Report and Mini Review on Clozapine Treatment During Chemotherapy: Is it Possible to Manage Neutropenia Successfully With Secondary G-CSF?
    Ceran S; Özel B; Altinoz AE; Çağatay Birer N; Oğuz A
    J Clin Psychopharmacol; 2024 Sep-Oct 01; 44(5):522-524. PubMed ID: 39173043
    [No Abstract]   [Full Text] [Related]  

  • 22. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.
    Hägg S; Rosenius S; Spigset O
    Int Clin Psychopharmacol; 2003 May; 18(3):173-4. PubMed ID: 12702898
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful Clozapine Rechallenge After Clozapine-Induced Severe Anemia: A Case Report.
    Barros FMR; Tolentino AC; Marques LSK; Schlittler LXC; Oliveira KD; Dalgalarrondo P; Barnes LL; Dos Santos Junior A; Banzato CEM
    Schizophr Bull; 2024 Apr; 50(3):717-719. PubMed ID: 38502910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of clozapine- and molindone-induced agranulocytosis with granulocyte colony-stimulating factor.
    Geibig CB; Marks LW
    Ann Pharmacother; 1993 Oct; 27(10):1190-4. PubMed ID: 7504534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monocytopenia in clozapine-induced agranulocytosis: insights into pathophysiology and treatment.
    Patel R; Lima A; Burke C; Hoffman M
    BMJ Case Rep; 2019 Jan; 12(1):. PubMed ID: 30661042
    [TBL] [Abstract][Full Text] [Related]  

  • 26. There Is Life After the UK Clozapine Central Non-Rechallenge Database.
    Oloyede E; Casetta C; Dzahini O; Segev A; Gaughran F; Shergill S; Mijovic A; Helthuis M; Whiskey E; MacCabe JH; Taylor D
    Schizophr Bull; 2021 Jul; 47(4):1088-1098. PubMed ID: 33543755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Restarting clozapine after neutropenia: evaluating the possibilities and practicalities.
    Whiskey E; Taylor D
    CNS Drugs; 2007; 21(1):25-35. PubMed ID: 17190527
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Add-on filgrastim during clozapine rechallenge in patients with a history of clozapine-related granulocytopenia/agranulocytosis.
    Joffe G; Eskelinen S; Sailas E
    Am J Psychiatry; 2009 Feb; 166(2):236. PubMed ID: 19188296
    [No Abstract]   [Full Text] [Related]  

  • 29. Treatment of clozapine-induced agranulocytosis with recombinant granulocyte colony-stimulating factor.
    Gullion G; Yeh HS
    J Clin Psychiatry; 1994 Sep; 55(9):401-5. PubMed ID: 7523362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful treatment of clozapine-induced agranulocytosis with granulocyte colony-stimulating factor.
    Raison CL; Guze BH; Kissell RL
    J Clin Psychopharmacol; 1994 Aug; 14(4):285-6. PubMed ID: 7525662
    [No Abstract]   [Full Text] [Related]  

  • 31. Clozapine and granulocyte colony-stimulating factor: potential for long-term combination treatment for clozapine-induced neutropenia.
    Mathewson KA; Lindenmayer JP
    J Clin Psychopharmacol; 2007 Dec; 27(6):714-5. PubMed ID: 18004146
    [No Abstract]   [Full Text] [Related]  

  • 32. Extended Requirement of Granulocyte Colony-Stimulating Factor for Clozapine-Associated Neutropenia.
    Leppla IE; Nucifora FC; Sedlak TW
    J Clin Psychopharmacol; 2019; 39(2):169-172. PubMed ID: 30811374
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.
    Yoshida M; Karasawa M; Naruse T; Fukuda M; Hirashima K; Oh H; Ninomiya H; Abe T; Saito K; Shishido H; Moriyama Y; Shibata A; Motoyoshi K; Nagata N; Miura Y
    Int J Hematol; 1999 Feb; 69(2):81-8. PubMed ID: 10071455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant human granulocyte colony-stimulating factor (rhG-CSF; filgrastim) treatment of clozapine-induced agranulocytosis.
    Nielsen H
    J Intern Med; 1993 Nov; 234(5):529-31. PubMed ID: 7693847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Filgrastim treatment of three patients with clozapine-induced agranulocytosis.
    Lamberti JS; Bellnier TJ; Schwarzkopf SB; Schneider E
    J Clin Psychiatry; 1995 Jun; 56(6):256-9. PubMed ID: 7539786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blood dyscrasias in clozapine-treated patients in Italy.
    Lambertenghi Deliliers G
    Haematologica; 2000 Mar; 85(3):233-7. PubMed ID: 10702809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. G-CSF plasma levels in clozapine-induced neutropenia.
    Jauss M; Pantel J; Werle E; Schröder J
    Biol Psychiatry; 2000 Dec; 48(11):1113-5. PubMed ID: 11094146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical safety of tbo-filgrastim, a short-acting human granulocyte colony-stimulating factor.
    Pettengell R; Bias P; Mueller U; Lang N
    Support Care Cancer; 2016 Jun; 24(6):2677-84. PubMed ID: 26780505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pegfilgrastim and daily granulocyte colony-stimulating factor: patterns of use and neutropenia-related outcomes in cancer patients in Spain--results of the LEARN Study.
    Almenar D; Mayans J; Juan O; Bueno JM; Lopez JI; Frau A; Guinot M; Cerezuela P; Buscalla EG; Gasquet JA; Sanchez J
    Eur J Cancer Care (Engl); 2009 May; 18(3):280-6. PubMed ID: 19076208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Failure of filgrastim to prevent severe clozapine-induced agranulocytosis.
    Majczenko TG; Stewart JT
    South Med J; 2008 Jun; 101(6):639-40. PubMed ID: 18475227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.